Thursday, July 24, 2025

3 Magnificent Stocks That Could Double or More by 2030

How does this make you feel?


In a turbulent stock market, three Motley Fool contributors recommend investing in CRISPR Therapeutics, Summit Therapeutics, and Viking Therapeutics, which they believe could see significant gains by 2030. CRISPR Therapeutics, despite recent struggles, has a promising gene-editing therapy, Casgevy, and a robust pipeline. Summit Therapeutics is poised to challenge established drugs with its ivonescimab, while Viking Therapeutics offers potential through its GLP-1 drug, VK2735, with ongoing clinical trials targeting obesity and metabolic disorders.

Full Article

Related Posts

The Smartest Cryptocurrency to Buy With $1,000 Right Now

Many cryptocurrencies have experienced significant gains recently, with XRP rising 60%, Ethereum more than doubling, and Bitcoin increasing by 27%. However, Polkadot, despite launching a next-generation technology upgrade, has only grown 19% in three months and remains down 40% over three years, suggesting it may present a more attractive investment opportunity compared to its peers. Want More Context? 🔎

Read more

EastGroup Posts 11% Revenue Gain in Q2

EastGroup Properties (NYSE: EGP), an industrial REIT focused on Sunbelt logistics, reported Q2 2025 GAAP revenue of $177.3 million, exceeding expectations, and non-GAAP earnings per share of $2.21. Despite revenue growth, occupancy declined slightly, indicating early caution in certain markets while maintaining pricing power on lease renewals. Want More Context? 🔎

Read more

Live Oak Posts Q2 Revenue Beat

Live Oak Bancshares (NYSE:LOB) reported Q2 2025 earnings on July 23, highlighting record loan production and deposit growth, resulting in total revenue of $143.7 million and EPS of $0.51, both surpassing analyst expectations. The bank, focused on small business lending and government-backed loans, demonstrated strong top-line momentum and improved cost efficiency, despite a dip in year-over-year GAAP profits. Want More Context? 🔎

Read more

Netflix Continues to Dominate

In this podcast episode, Motley Fool host Anand Chokkavelu, along with contributors Jason Hall and Matt Frankel, discusses Netflix's ongoing dominance in the streaming industry and highlights key investment insights. Listeners are encouraged to explore the full range of Motley Fool's free podcasts and consider a top 10 list of stocks for potential investment. Want More Context? 🔎

Read more

Welcome Back!

Login to your account below

Retrieve your password

Please enter your username or email address to reset your password.